Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) in Treating Chronic Hepatitis B Patients

NCT02862106 is registered in ClinicalTrials.gov with Chongqing Jiachen Biotechnology Ltd. as lead sponsor.

NCT NCT02862106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02862106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) in Treating Chronic Hepatitis B Patients
Lead sponsor
Chongqing Jiachen Biotechnology Ltd.
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2010
Completion date
March 31, 2013
Enrollment
209 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b